Clinical Trial Update: Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2 [Phase 2]

View source ↗

Summary

Pembrolizumab was studied in a Phase 2 trial in non-small cell lung cancer patients with performance status 2; the study has completed and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University of Birmingham | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2025-02-10